touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease

    touchEXPERT FOCUS for touchONCOLOGY

    Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits. 

    The experts:

    • Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
    • Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
    • Prof. Peter Schmid – Barts Cancer Institute, London, UK

      • This touchPODCAST is for healthcare professionals outside of the UK.

      This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. 

      This activity is jointly provided by USF Health and touchIME.

      touchIME is an EBAC® accredited provider.

      For further information visit our website:

      https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/

      37 min
    • Applying immunotherapy in clinical practice for patients with early-stage NSCLC

      touchEXPERT FOCUS for touchRESPIRATORY

      Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.

      The expert

      • Prof. Jonathan Spicer, McGill University, Montreal, Canada

        • This touchPODCAST is for HCPs outside of the UK only.

        This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

        The activity is jointly provided by USF Health and touchIME.

        touchIME is an EBAC® accredited provider.


        For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/

         

        17 min
      • Applying immunotherapy in clinical practice for patients with early-stage NSCLC

        touchEXPERT FOCUS for touchONCOLOGY

        Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.

        The expert

        • Prof. Jonathan Spicer, McGill University, Montreal, Canada

          • This touchPODCAST is for HCPs outside of the UK only.

          This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

          The activity is jointly provided by USF Health and touchIME.

          touchIME is an EBAC® accredited provider.


          For further information, visit our website: https://touchoncologyime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/

           

          17 min
        • Towards personalized care for people living with HIV: Supporting open dialogue and informed treatment choices

          NEW touchCASES for touchINFECTIOUS DISEASES

          Listen to  Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation.

          The experts:

          • Prof. José Arribas, University Hospital La Paz, Madrid, Spain,
          • Ms Harriet Langanke, GSSG, Cologne, Germany

            • This touchPODCAST is for HCPs outside of the UK

            This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME.

            touchIME is an EBAC® accredited provider.

            For further information, visit our website: https://touchinfectiousdiseases.com

            35 min
          • Accelerating myasthenia gravis diagnosis and treatment: Practical strategies and therapeutic advances

            touchIN CONVERSATION for touchNEUROLOGY

            Listen as two experts discuss the practical considerations for the diagnosis of myasthenia gravis (MG), serological subgroup testing and the implementation of newly available treatments for MG. They will also consider the emerging treatments for generalized MG and the potential impact on the therapeutic landscape.

            The experts

            • Dr Carolina Barnett-Tapia, University of Toronto, Toronto, ON, Canada
            • Prof. Nils Erik Gilhus, University of Bergen and Haukeland University Hospital, Bergen, Norway

              • This touchPODCAST is for HCPs outside of the UK.

              This activity is funded by an independent medical education grant from Healthcare

              Business of Merck KGaA, Darmstadt, Germany. 

              This activity is jointly provided by USF Health and touchIME. 

              touchIME is an EBAC® accredited provider.

              For further information visit our website: www.touchneurology.com

              40 min
            • RET-positive NSCLC: Translating insights into targeted approaches

              touchFOCUS for touchRESPIRATORY

              In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.

              The expert:

              • Dr Christine Bestvina - University of Chicago, Chicago, IL, USA

                • This touchPODCAST is for HCPs outside the UK. 


                This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.

                This activity is jointly provided by USF Health and touchIME.

                For further information visit our website: touchrespiratory.com

                15 min
              • RET-positive NSCLC: Translating insights into targeted approaches

                touchFOCUS for touchONCOLOGY

                In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.

                The expert:

                • Dr Christine Bestvina - University of Chicago, Chicago, IL, USA

                  • This touchPODCAST is for HCPs outside the UK. 

                  This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.


                  This activity is jointly provided by USF Health and touchIME.

                  For further information visit our website: touchoncology.com

                  15 min
                • Advances in dry eye disease: From diagnosis to new treatment targets

                  touchEXPERT FOCUS touchOPHTHALMOLOGY

                  Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today.

                   

                  The expert

                  • Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA

                    • This touchPODCAST is for HCPs outside of the UK. 

                    This activity is funded by an independent medical education grant from Alcon Vision, LLC.

                    The activity is jointly provided by USF Health and touchIME. 


                    For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/

                     

                    38 min
                  • Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus

                    touchIN CONVERSATION for touchOPHTHALMOLOGY

                    Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monitoring treatment outcomes and evaluating effectiveness of therapy in clinical practice. 

                    The experts

                    • Prof. Giuseppe Querques, IRCCS Hospital San Raffaele, Milan, Italy
                    • Dr Arshad M. Khanani, Sierra Eye Associates, Reno, NV, USA

                      • This touchPODCAST is for HCPs outside of the UK. 

                      This activity is funded by an independent medical education grant from Astellas Pharma Inc.

                      The activity is jointly provided by USF Health and touchIME. 

                      touchIME is an EBAC® accredited provider.

                      For further information, visit our website: https://touchophthalmologyime.org/

                      36 min
                    • The potential of BTKi therapies in delaying MS progression

                      touchEXPERT FOCUS for touchNEUROLOGY

                      Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalban also considers current guideline-recommended therapies for progressive MS and highlights key areas of remaining unmet treatment need.

                      The expert

                      Prof. Xavier Montalban, Centre d'Esclerosi Múltiple de Catalunya (Cemcat) and Vall d'Hebron University Hospital, Barcelona, Spain

                      This touchPODCAST is for HCPs outside of the UK only.

                      This activity is provided by an independent medical education grant from Sanofi. 

                      The activity is jointly provided by USF Health and touchIME. 

                      touchIME is an EBAC® accredited provider.

                      For further information visit our website: https://touchneurology.com/ 

                      14 min

                    About touchPODCAST

                    From the publisher's feed

                    Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.